GCC pharmaceutical regulations are evolving with centralized registration, stricter Saudi SFDA/UAE MoHAP policies, enhanced pharmacovigilance, digital submissions, and growing use of real-world evidence.
Emerging Trends Shaping Pharmaceutical Regulations in the GCC and Middle East Read More »
GCC pharmaceutical regulations are rapidly evolving, requiring updated compliance strategies for Saudi SFDA, UAE MOHAP, eCTD v4.0 submissions, pharmacovigilance, reliance pathways, and SaMD/AI regulation.
PharmaOasis Germans EG offers expert regulatory consultancy to accelerate healthcare product launches in the Middle East and GCC, ensuring faster approvals, tailored strategies, and market success.
Accelerate Your Healthcare Product Launch in the Middle East and GCC Read More »
